Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) Stock Information | RedChip

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) Listen to this Section


$2.34
-0.0100 ( -0.43% ) 296.0K

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Market Data


Open


$2.34

Previous close


$2.35

Volume


296.0K

Market cap


$95.07M

Day range


$2.33 - $2.48

52 week range


$1.67 - $3.67

Insider Ownership Transactions

Total Amount Purchased: -1,069,350.00 | $ -2,502,279.00

Date Type Amount Purchased Purchaser
2024-06-21 Sale -140040.00 Gabay Avraham
2024-06-10 Sale -760.00 Reznick Yehuda
2024-04-18 Sale -29800.00 Reznick Yehuda
2024-01-30 Sale -3750.00 Aghion Daniel
2024-01-08 Sale -30000.00 Rozov Yadin
2024-01-08 Sale -30000.00 Sank Leonard
2024-01-08 Sale -30000.00 Mayer Arie
2024-01-08 Sale -180500.00 Hexter Joshua
2024-01-08 Sale -329000.00 KIDRON NADAV
2024-01-08 Sale -295500.00 Kidron Miriam

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 51 Aug 14, 2024
8-k 8K-related 13 Aug 02, 2024
8-k 8K-related 13 Jun 26, 2024
8-k 8K-related 13 Jun 24, 2024
3 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
ars Annual reports 1 Jun 20, 2024
def Proxies and info statements 5 Jun 20, 2024
8-k 8K-related 13 Jun 10, 2024
4 Insider transactions 1 Jun 10, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.